| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/09537104.2012.698431 |
| P698 | PubMed publication ID | 22774770 |
| P2093 | author name string | Hong-Zhe Zhang | |
| Moo Hyun Kim | |||
| Long Hao Yu | |||
| P2860 | cites work | Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests | Q43289685 |
| Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis | Q43416611 | ||
| High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention | Q43989417 | ||
| High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability. | Q45136309 | ||
| Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platele | Q46119763 | ||
| The effect of ex vivo anticoagulants on whole blood platelet aggregation | Q46145122 | ||
| Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up | Q46178120 | ||
| Clopidogrel resistance in Japanese patients scheduled for percutaneous coronary intervention | Q46184554 | ||
| Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation | Q46761762 | ||
| High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting. | Q50059973 | ||
| Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial. | Q51501093 | ||
| High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype. | Q53398996 | ||
| Platelet function testing in cardiovascular diseases | Q28171455 | ||
| Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug | Q28187017 | ||
| Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial | Q28194232 | ||
| A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease | Q28195458 | ||
| Clinical aspects of platelet inhibitors and thrombus formation | Q28210313 | ||
| Oral antiplatelet therapy for percutaneous coronary revascularization | Q28220708 | ||
| Biology and pharmacology of the platelet P2Y12 receptor | Q36447310 | ||
| Platelet function monitoring in patients with coronary artery disease | Q36990868 | ||
| Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. | Q37786695 | ||
| Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation | Q38375573 | ||
| Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay | Q43234549 | ||
| P433 | issue | 5 | |
| P921 | main subject | aspirin | Q18216 |
| clopidogrel | Q410237 | ||
| anticoagulant | Q215118 | ||
| hirudin | Q386715 | ||
| anticoagulation | Q63279445 | ||
| P304 | page(s) | 339-347 | |
| P577 | publication date | 2012-07-09 | |
| P1433 | published in | Platelets | Q1573582 |
| P1476 | title | Effect of different anticoagulants on multiple electrode platelet aggregometry after clopidogrel and aspirin administration in patients undergoing coronary stent implantation: a comparison between citrate and hirudin | |
| P478 | volume | 24 |
| Q53437152 | Assessing the influence of diurnal variations and selective Xa inhibition on whole blood aggregometry. |
| Q43710350 | Defining predictive values using three different platelet function tests for CYP2C19 phenotype status on maintenance dual antiplatelet therapy after PCI. |
| Q35620590 | Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease |
| Q44398909 | Rapid evaluation of platelet function using the Multiplate® Analyzer |
Search more.